Androisoxazole

Androisoxazole
Clinical data
Trade names	Androxan, Neo-Ponden, Neo-Pondus
Other names	17α-Methyl-5α-androstano[3,2-c]isoxazol-17β-ol
Routes of; administration	By mouth
Drug class	Androgen; Anabolic steroid
Identifiers
	IUPAC name 2,3,3a,3b,4,5,5a,6,10,10a,10b,11,12,12a-tetradecahydro-1,10a,12a-trimethyl-1H-cyclopenta[7,8]phenanthro[2,3-c]isoxazol-1-ol;
CAS Number	360-66-7 [correct];
PubChem CID	9676;
ChemSpider	9295 ;
UNII	6WRG30P3CG;
CompTox Dashboard (EPA)	DTXSID40957423 ;
Chemical and physical data
Formula	C21H31NO2
Molar mass	329.484 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O[C@@]5(C)CC[C@H]4[C@H]3[C@@H]([C@]2(Cc1c(noc1)C[C@@H]2CC3)C)CC[C@@]45C;
	InChI InChI=1S/C21H31NO2/c1-19-11-13-12-24-22-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)23/h12,14-17,23H,4-11H2,1-3H3/t14-,15+,16-,17-,19-,20-,21-/m0/s1 ; Key:NSYTUNFHWYMMHU-IYRCEVNGSA-N ;
	(verify)

Androisoxazole (brand names Androxan, Neo-Ponden, Neo-Pondus), also known as 17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol, is an orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of dihydrotestosterone (DHT) that is marketed in Spain and Italy. It is closely related to stanozolol, differing only in having an isoxazole instead of pyrazole ring fused to the A ring, and is also related to furazabol, prostanozol, and danazol.